Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
5.95
+0.07 (1.19%)
At close: Sep 11, 2026, 4:00 PM EDT
5.95
0.00 (-0.08%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $290.78 million as of September 11, 2026.
Market Cap
290.78M
Enterprise Value
111.40M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.95
ChartMarket Cap Chart
Since July 20, 2026, Clinuvel Pharmaceuticals's market cap has decreased from $371.50M to $290.78M, a decrease of -21.73%. That is a compound annual growth rate of -82.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 295.20M | -0.84% |
| Sep 9, 2026 | 297.70M | -1.33% |
| Sep 8, 2026 | 301.70M | -7.82% |
| Sep 4, 2026 | 327.30M | 3.81% |
| Sep 3, 2026 | 315.30M | 1.32% |
| Sep 2, 2026 | 311.20M | -0.67% |
| Sep 1, 2026 | 313.30M | 4.89% |
| Aug 31, 2026 | 298.70M | -3.40% |
| Aug 28, 2026 | 309.20M | -9.03% |
| Aug 27, 2026 | 339.90M | -11.37% |
| Aug 26, 2026 | 383.50M | 0.52% |
| Aug 25, 2026 | 381.50M | 2.42% |
| Aug 24, 2026 | 372.50M | -4.88% |
| Aug 21, 2026 | 391.60M | - |
| Aug 20, 2026 | 391.60M | 9.11% |
| Aug 19, 2026 | 358.90M | 3.61% |
| Aug 18, 2026 | 346.40M | 0.29% |
| Aug 17, 2026 | 345.40M | -0.29% |
| Aug 14, 2026 | 346.40M | 2.61% |
| Aug 13, 2026 | 337.60M | 0.69% |
| Aug 12, 2026 | 335.30M | -2.64% |
| Aug 11, 2026 | 344.40M | 1.77% |
| Aug 10, 2026 | 338.40M | 0.92% |
| Aug 7, 2026 | 335.30M | -0.65% |
| Aug 6, 2026 | 337.50M | 3.37% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 316.63M |
| Lyell Immunopharma | 315.63M |
| Agenus | 308.84M |
| InflaRx | 308.00M |
| Sutro Biopharma | 304.35M |
| Immuneering | 298.26M |
| Fulcrum Therapeutics | 292.98M |
| Fate Therapeutics | 292.36M |